Search research articles
Contact Us
Filters
Showing results (101-110 of 134) with videos related to
Page
of 14
Sort By:
Atherosclerosis
|
September 29, 2007
Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study
J A Troughton, J V Woodside, J W G Yarnell, et al.
Circulation
|
February 1, 1996
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde
I Behague, O Poirier, V Nicaud, et al.
Atherosclerosis
|
March 19, 2014
Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects
S Béliard, V Carreau, A Carrié, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
June 1, 1992
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study
H J Parra, D Arveiler, A E Evans, et al.
Journal of Hypertension
|
April 9, 1998
Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Gènes de l'Hypertension Artérielle Sévère à modérée Essentielle
L Tiret, H Blanc, J B Ruidavets, et al.
Atherosclerosis
|
January 5, 1996
Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study
A Lane, F Green, P Y Scarabin, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
June 1, 1993
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study
P Y Scarabin, L Bara, S Ricard, et al.
Circulation
|
December 16, 1998
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha
A Mamontova, S Séguret-Macé, B Esposito, et al.
European Journal of Human Genetics : EJHG
|
September 16, 2004
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study
P E Morange, L Tiret, N Saut, et al.
Thrombosis and Haemostasis
|
September 1, 1995
The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde
S Ye, F R Green, P Y Scarabin, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 134) with videos related to
Sort By:
Page
of 14
Atherosclerosis
|
September 29, 2007
Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study
J A Troughton, J V Woodside, J W G Yarnell, et al.
Circulation
|
February 1, 1996
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde
I Behague, O Poirier, V Nicaud, et al.
Atherosclerosis
|
March 19, 2014
Improvement in LDL-cholesterol levels of patients with familial hypercholesterolemia: can we do better? Analysis of results obtained during the past two decades in 1669 French subjects
S Béliard, V Carreau, A Carrié, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
June 1, 1992
A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study
H J Parra, D Arveiler, A E Evans, et al.
Journal of Hypertension
|
April 9, 1998
Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Projet d'Etude des Gènes de l'Hypertension Artérielle Sévère à modérée Essentielle
L Tiret, H Blanc, J B Ruidavets, et al.
Atherosclerosis
|
January 5, 1996
Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study
A Lane, F Green, P Y Scarabin, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
June 1, 1993
Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study
P Y Scarabin, L Bara, S Ricard, et al.
Circulation
|
December 16, 1998
Severe atherosclerosis and hypoalphalipoproteinemia in the staggerer mouse, a mutant of the nuclear receptor RORalpha
A Mamontova, S Séguret-Macé, B Esposito, et al.
European Journal of Human Genetics : EJHG
|
September 16, 2004
TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study
P E Morange, L Tiret, N Saut, et al.
Thrombosis and Haemostasis
|
September 1, 1995
The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde
S Ye, F R Green, P Y Scarabin, et al.
Page
of 14